ARIAD Pharmaceuticals

About:

ARIAD is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients.

Website: http://www.ariad.com

Twitter/X: ARIADPharm

Top Investors: Credit Suisse, Merlin Biomed

Description:

ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines. This is our purpose. This is our passion. This is our promise.

Total Funding Amount:

$88.5M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

1991-01-01

Contact Email:

investor(AT)ariad.com

Founders:

Harvey Berger, Larry Bock

Number of Employees:

251-500

Last Funding Date:

2006-10-20

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai